BioRestorative Therapies
BRTX
18 hedge funds and large institutions have $1M invested in BioRestorative Therapies in 2026 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
900% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 1
444% more capital invested
Capital invested by funds: $184K → $1M (+$818K)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more funds holding
Funds holding: 9 → 18 (+9)
7.8% more ownership
Funds ownership: 2.66% → 10.46% (+7.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$235K |
| 2 |
HF
HRT Financial
New York
|
+$208K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$83.8K |
| 4 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
+$41.5K |
| 5 |
Citigroup
New York
|
+$18.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$29.2K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$20.7K |
BRTX Hedge Fund Activity: Q2 2026 in Review
18 of the 8,345 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q2 2026, worth a combined $1M — up 444% from $184K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new BRTX positions and 1 closed out — a net gain of 9 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $235K. The largest seller was UBS Group, exiting entirely with an estimated $29.2K sold.
- 18 institutional investors held BioRestorative Therapies (BRTX) as of Q2 2026, up from 9 in Q1 2026.
- Funds reported $1M of BioRestorative Therapies stock for Q2 2026, up 444% quarter-over-quarter.
- 10 funds opened new BioRestorative Therapies positions in Q2 2026 and 1 closed out, a net change of +9 holders.
- The largest BioRestorative Therapies buyer in Q2 2026 was Jane Street, an estimated $235K added.
- The largest BioRestorative Therapies seller in Q2 2026 was UBS Group, an estimated $29.2K sold.
Based on aggregated 13F filings for Q2 2026.